Spots Global Cancer Trial Database for Human Papillomavirus in Cervical Cancer and Pre-cancer in Switzerland: The CIN3+Plus Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Human Papillomavirus in Cervical Cancer and Pre-cancer in Switzerland: The CIN3+Plus Study
Official Title: Human Papillomavirus-Associated Cervical Neoplasia in Switzerland at the Start of a National Vaccination Programme: Crosssectional Study
Study ID: NCT02323997
Conditions
Interventions
Study Description
Brief Summary: This study will investigate the types of HPV in samples from women with cervical pre-cancer and cancer and gather information to help investigate the impact of HPV vaccination in Switzerland.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Viollier AG, Allschwil, Baselland, Switzerland
Universitätsspital Basel, Basel, , Switzerland
Viollier Weintraub SA, Geneva, , Switzerland
HUG - Hôpitaux Universitaires de Genève, Geneva, , Switzerland
Kantonsspital Baselland, Liestal, , Switzerland
Istituto cantonale di patologia, Locarno, , Switzerland
Kantonsspital Luzern, Luzern, , Switzerland
Institute of Pathology Enge, Zurich, , Switzerland
Institut für klinische Pathologie Medica, Zurich, , Switzerland
Universitätsspital Zürich, Zürich, , Switzerland
Contact Details
Name: Nicola Low
Affiliation: University of Bern, Institute of Social and Preventive Medicine
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
